R&D Pipeline

Current Research Projects
ProjectCallFunding AgencyRoleActivitiesExecution Period

Develop a sustainable platform for new therapies based on oligonucleotides (ASOs, siRNAs and aptamers for the treatment of rare diseases.


AptusBiotech will be in charge of developing novel aptamers for the detection of specific antibiotics used in clinics

AptaBreastRTC2019-007227-1CoordinatorMnk1 aptamer for breast cancer novel therapy. Preclinical Trials in animal models.2020 – 2023
PrediAptRTC2019-007229-1CoordinatorDevelopment of a Predictive System based on Aptamers in response to Treatment with Platinum Derivatives in Lung Cancer2020-2023
EURONANOMED 2018-045PartnerSelection of aptamers against a lung cancer marker and their use for targeting in drug delivery and thus interrupting metastatic progression. 2018-2021
Relevant previous projects in which the entity has participated
ProjectCallFunding AgencyRoleActivities  
AptalungRTC-2017-6597-1CoordinatorLung Cancer Diagnosis Using Aptamer technology. Applications in analysis of circulating tumor cells (CTCs) and in Apta-histochemistry.2018-2021
AptaVirRETOS 2016 MINECO (RTC-2016-5302-1)Partner

Development and manufacture of portable solutions for direct detection of the Chikungunya virus for rapid diagnosis.

MultiDETECTPrograma CDTI-interempresas 2016 EUROSTARS-2 (E9781)Partner

Aptamers against proteins of seven porcine pathogens with the aim of developing a multiple diagnostic kit for the detection of respiratory and digestive infections in swine.

ApTOLLRETOS 2015 MINECO (RTC-2015-3741-1)Partner

Preclinical development of a molecule based on aptamer technology specific to TLR-4 and applicable in Acute Stroke and Cardiovascular Diseases (Myocardial Infarction).

AptaHCVRETOS 2014 MINECO (RTC-2014-1986-1)Partner

Development and validation of an aptamer-based platform for the detection and genotyping of hepatasis C virus.

Subprogramm “Innpacto 2011IPT-2011-1057-010000 PartnerDevelopment and clinical validation of a Kit to diagnose the evolution of intestinal absorptive mass, using innovative technology based on selective aptamers of the APO A-IV protein2011-2014